Clinical Site

Little Rock, Arkansas 72211

1 studies enrolling now · 11 studies all time

What they study most

Bipolar Depression, Bipolar Disorder, Manic, Cardiovascular Diseases, Generalized Anxiety Disorder, Hypertriglyceridemia, Major Depressive Disorder, Schizophrenia

Studies at this site

• Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder — Recruiting now
• Study of Lumateperone in the Treatment of Patients With Bipolar Mania — Completed
• A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With Schizophrenia — Completed
• An Open-label Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder — Completed
• Clinical Trial Evaluating ITI-007 (Lumateperone) as a Monotherapy for the Treatment of Bipolar Depression — Completed
• Study of a Novel Antipsychotic ITI-007 in Schizophrenia — Completed
• A Trial to Assess the Antipsychotic Efficacy of ITI-007 Over 6 Weeks of Treatment — Completed
• A Trial to Assess the Antipsychotic Efficacy of ITI-007 — Completed
• Multicenter Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder — Completed
• Lumateperone for the Prevention of Relapse in Patients With Schizophrenia — Completed
• Study of ISIS 678354 (AKCEA-APOCIII-LRx) in Participants With Hypertriglyceridemia and Established Cardiovascular Disease (CVD) — Completed